The European Medicines Agency says it expects an application for conditional marketing to be submitted by AstraZeneca next week.
It comes as the European Commission agreed to buy an additional 200 million doses of the Pfizer Bio-N-Tech vaccine.
The Moderna vaccine has also been approved for use by the EU.
Executive Director of the EMA, Emer Cooke says they are working as fast as possible to approve Covid vaccines.